Drugs.com - Monthly Update June 2025
Автор: Drugs.com
Загружено: 2025-12-15
Просмотров: 18
Описание:
This is the June 2025 edition of the Drugs.com Monthly Update. We cover five significant FDA approvals that are transforming patient care across multiple therapeutic areas.
• Dupixent (https://www.drugs.com/dupixent.html) (dupilumab), newly approved for treating bullous pemphigoid in adults—a painful autoimmune skin disorder primarily affecting patients over 65.
• Mavyret (https://www.drugs.com/mavyret.html) (glecaprevir/pibrentasvir) for acute hepatitis C virus treatment in children as young as 3 years old.
• Yeztugo (https://www.drugs.com/yeztugo.html) (lenacapavir), a groundbreaking twice-yearly injectable HIV prevention therapy offering a 99.9% effectiveness rate in clinical trials.
• Enflonsia (https://www.drugs.com/enflonsia.html) (clesrovimab-cfor), a new RSV prevention option for neonates and infants that provides season-long protection with a single injection.
• Ibtrozi (https://www.drugs.com/ibtrozi.html) (taletrectinib), an oral targeted therapy approved for ROS1-positive non-small cell lung cancer in patients with locally advanced or metastatic disease.
Chapters:
• (00:00) - Intro
• (00:24) - Overview
• (00:45) - Dupixent
• (01:38) - Mavyret
• (02:14) - Yeztugo
• (03:14) - Enflonsia
• (03:54) - Ibtrozi
• (04:26) - Outro
Follow Drugs.com:
• X ( / drugscom ) , Facebook ( / drugscom ) , Youtube ( / drugscom )
• Signup to our newsletters (https://www.drugs.com/newsletters/)
• Download the app (https://www.drugs.com/apps/)
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: